CClinicalTrials.gg
CompletedNCT06203665Updated Mar 20, 2024

Restoration of Pulmonary Compliance After Laparoscopic Gynaecologic Surgery Using a Recruitment Maneuver

An interventional study of Recruitment Maneuver in Atelectasis and Compliance, Patient, sponsored by Panagiota Griva. Completed at 1 site in Greece. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-20.

Sponsored by Panagiota Griva · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jun 2023, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

To investigate the hypothesis that an alveolar recruitment maneuver after the release of pneumoperitoneum would restore the lung compliance to the baseline values after a laparoscopic gynaecologic surgery.

Read the detailed description

In recent years, laparoscopic surgery is a common minimal invasive technique which ensures the avoidance of prolong hospital stay, long duration surgery, postoperative pain, operation scars. However, laparoscopic surgery has a negative impact on respiratory mechanics because of the pneumoperitoneum, the changes in position and the appliance of positive pressure ventilation. The increase in abdominal pressure as a result of carbon dioxide insufflation and the typical head-down body position have been shown to impair respiratory function. Application of a pneumoperitoneum-induced elevation of intraabdominal pressure elevates the diaphragm and results in a compression of the dependent ventral lung regions. As a consequence, the amount of atelectasis is increased. The insufflation of CO2 reduced respiratory system compliance, and increased peak inspiratory and mean airway pressures. Additionally, changes to the lithotomy and Trendelenburg position during gynaecologic surgery reduce lung compliance by altering the location of intestinal contents and diaphragm. Especially the Trendelenburg position potentiates the effects of abdominal pressure via gravity and relaxation of the diaphragm; thereby, increasing the airway pressure and reducing the functional residual capacity, which results in further changes in the respiratory system. Therefore, we evaluated the effect of an alveolar recruitment maneuver during gynaecologic laparoscopic surgery by determining the changes in lung compliance.

Design: Prospective study. Setting: Operating room of a hospital. Patients: 31 ASA physical status I and II patients scheduled to undergo gynaecologic laparoscopic surgery in the dorsal lithotomy position.

Interventions: The surgery would be performed under general anaesthesia according to the common practice using protective lung ventilation ( Vt= 6 ml /Kg ideal body weight , RR to maintain end-expiratory CO2 35-45 cmH2O and PEEP= 6- 8 cm H20). An incremental and decremental positive end-expiratory pressure alveolar recruitment maneuver would be performed after release of pneumoperitoneum.

Measurements: Respiratory mechanics including dynamic compliance were measured continuously. Respiratory measures were recorded together with arterial blood gases after induction (T1), with the patient placed in the dorsal lithotomy position (T2), 10 and 90 minutes after CO2 insufflation (T3 and T4), immediately after desufflation in the lithotomy and supine positions (T5 and T6), and 10 minutes after a pulmonary recruitment maneuver at the conclusion of surgery (T7).

Inclusion criteria:

  • >18 years old patients
  • A gynaecologic laparoscopic surgery would be performed
  • Duration of the surgery over 90 minutes

Exclusion criteria:

  • Chronic Obstructive Lung Disease with FEV1 \< 60 of predicted value
  • Lung Emphysema
  • BMI > 30
  • Hemodynamic instability during the operation
  • Acute cor pulmonale
02

Conditions studied

  • Atelectasis
  • Compliance, Patient

Browse trials for

03

In context

Pulmonary Atelectasis

301 studies on the registry are indexed under Pulmonary Atelectasis; 80 are open to participants now.

This study's enrollment of 31 is below the median of 61 across 222 interventional studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

This is the only study on the registry with Panagiota Griva as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • >18 years old patients
  • A gynaecologic laparoscopic surgery would be performed
  • Duration of the surgery over 90 minutes

Exclusion criteria

Exclusion Criteria:

  • Chronic Obstructive Lung Disease with FEV1 \< 60 of predicted value
  • Lung Emphysema
  • BMI > 30
  • Hemodynamic instability during the operation
  • Acute cor pulmonle
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Patients enrolled in the protocol

    An alveolar recruitment nameuver will be performed after the release of pneumoperitoneum

    Diagnostic Test: Recruitment Maneuver

Interventions

  • Diagnostic testRecruitment Maneuver

    The surgery would be performed under general anaesthesia according to the common practice using protective lung ventilation ( Vt= 6 ml /Kg ideal body weight , RR to maintain end-expiratory CO2 35-45 cmH2O and PEEP= 6- 8 cm H20). An incremental and decremental positive end-expiratory pressure alveolar recruitment maneuver would be performed after release of pneumoperitoneum.

06

What researchers measure

Primary outcomes

  1. Delta (Δ) Compliance (T1 -T7)

    The compliance difference between T1 and T7, where T1 denotes the time of induction to anaesthesia and T7 is the release of pneumoperitoneum time.

    Time frame: intraoperative, after anesthesia induction and after the release of pneumoperitoneum

  2. Delta (Δ) Compliance (T1 -T8)

    The compliance difference between T1 and T8, where T8 is the time of the recruitment maneuver.

    Time frame: intraoperative, after anesthesia induction and after the recruitment maneuver

  3. Delta (Δ) Compliance (T7 -T8)

    The different compliance between T7 and T8

    Time frame: intraoperative, after the release of pneumoperitoneum and after the recruitment maneuver

Secondary outcomes

  1. Compliance (in mL/cmH2O)

    Compliance of the lungs measured at the following time frames: after anesthesia induction (T1), after dorsal lithotomy position (T2), after Trendelenburg position (T3), 10 and 90 minutes after CO2 insufflation (T4, T5 respectively), after removal of Trendelenburg position (T6), after desufflation (T7), 10 minutes after an alveolar recruitment maneuver (T8).

    Time frame: intraoperative (T1-T8)

  2. Pplateau (in cmH2O)

    end-inspiratory airway pressure measured at the following time frames: after anesthesia induction (T1), after dorsal lithotomy position (T2), after Trendelenburg position (T3), 10 and 90 minutes after CO2 insufflation (T4, T5 respectively), after removal of Trendelenburg position (T6), after desufflation (T7), 10 minutes after an alveolar recruitment maneuver (T8).

    Time frame: intraoperative (T1-T8)

  3. MAP (in mmHg)

    Mean Arterial Pressure measured at the following time frames: after anesthesia induction (T1), after dorsal lithotomy position (T2), after Trendelenburg position (T3), 10 and 90 minutes after CO2 insufflation (T4, T5 respectively), after removal of Trendelenburg position (T6), after desufflation (T7), 10 minutes after an alveolar recruitment maneuver (T8).

    Time frame: intraoperative (T1-T8)

  4. Intraoperative administration of vasoactive agents

    The dose of the vasoactive agents administrated to maintain a Mean Arterial Pressure \> 65mmHg during the alveolar recruitment maneuver

    Time frame: intraoperative, after alveolar recruitment maneuver

07

Study locations

1 site
  • General Hospital of Athens "Alexandra"
    Athens, Attica 11528, Greece
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06203665
Lead sponsor
Panagiota Griva
Responsible party
Panagiota Griva (Resident Doctor, National and Kapodistrian University of Athens) — Sponsor-investigator
First posted
Jan 12, 2024
Start date
Jun 7, 2023
Primary completion
Feb 1, 2024
Completion
Mar 5, 2024
Last update
Mar 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion